Interleukin-2 inhalation therapy temporarily induces asthma-like functional changes and airway inflammation

R. A. Jörres, D. Loppow, E. Huland, H. Heinzer, L. Grönke, O. Holz, H. Magnussen (Grosshansdorf, Hamburg, Germany)

Source: Annual Congress 2003 - Asthma
Session: Asthma
Session type: Thematic Poster Session
Number: 3021
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. A. Jörres, D. Loppow, E. Huland, H. Heinzer, L. Grönke, O. Holz, H. Magnussen (Grosshansdorf, Hamburg, Germany). Interleukin-2 inhalation therapy temporarily induces asthma-like functional changes and airway inflammation. Eur Respir J 2003; 22: Suppl. 45, 3021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Benralizumab attenuates airway eosinophilopoietic processes in prednisone-dependent asthma
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017




In vivo blockade of CTLA-4 counteracts inhalation tolerance and leads to development of allergic airway inflammation in mice repeatedly exposed to aerosolized ovalbumin
Source: Eur Respir J 2004; 24: Suppl. 48, 6s
Year: 2004

Effects of budesonide/formoterol maintenance therapy on airway hyperresponsiveness and inflammation in an allergic rat model
Source: Eur Respir J 2004; 24: Suppl. 48, 351s
Year: 2004

Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007

IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation.
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018



The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007


IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019

IL-33 and airway remodelling in paediatric severe therapy resistant asthma
Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood
Year: 2012

Short-term treatment with sistemic corticosteroids blunted neutrophilic airway response to ozone in mild asthmatics
Source: Eur Respir J 2002; 20: Suppl. 38, 569s
Year: 2002

Low-level laser therapy effect on the bronchial hyperresponsiveness and the chronic allergy airway inflammation is driven to RhoA signaling and STAT-6
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013

Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma
Source: International Congress 2018 – Basic pharmacology
Year: 2018

Effect of previous physical conditioning on pulmonary inflammation and allergic immune response in a chronic allergic airway inflammation in mice
Source: Eur Respir J 2007; 30: Suppl. 51, 370s
Year: 2007

Correlation between airway inflammation and loss of deep inhalation bronchoprotection in asthmatics
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007


Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012

Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010


Effects of active and passive smoking on allergic airway inflammation and airway hyperresponsiveness in mice
Source: Eur Respir J 2002; 20: Suppl. 38, 310s
Year: 2002

Formoterol protects against platelet-activating factor-induced effects in asthma
Source: Eur Respir J 2004; 23: 71-75
Year: 2004



Corticosteroid-resistant neutrophilic airway inflammation and hyperresponsiveness caused by IL-13
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018

Role of IL-33 signaling in pollutant-induced allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018


A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002